The drug epidemic: Effects on newborn infants and health resource consumption at a tertiary perinatal centre

Journal of Paediatrics and Child Health

Volumn 36, Issue 3, 2000, Pages 262-264

  Kelly, J J ^a   Davis, P G ^a   Henschke, P N ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Infant newborn; Neonatal abstinence syndrome; Substance related disorders

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; AUSTRALIA; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE PLANNING; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADULT; AMBULATORY CARE FACILITIES; AMPHETAMINES; AUSTRALIA; BENZODIAZEPINES; CANNABIS; COCAINE; COMORBIDITY; FEMALE; HEALTH RESOURCES; HEROIN; HOSPITALS, URBAN; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LENGTH OF STAY; LYSERGIC ACID DIETHYLAMIDE; MALE; MATERNAL-FETAL EXCHANGE; MEDICAL AUDIT; METHADONE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS;

EID: 0034120140     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2000.00492.x     Document Type: Article

References (14)

1. 1 Hall WD, Degenhardt LJ, Lynskey MT. Opioid overdose mortalily in Australia. 1964-97: Birth-cohort trends. Med. J. Aust. 1999; 171: 34-7.
2. 2 Ali RL, Quigley AJ. Accidental drug toxicity associated with methadone maintenance treatment. Med. J. Aust. 1999; 170: 100-1.
3. 3 Anonymous. Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs. Pediatrics 1998; 101: 1079-88.
4. 4 Oats JN, Beischer NA, Breheny JE, Pepperell RJ. The outcome of pregnancies complicated by narcotic drug addiction. Aust. N.Z. J. Obstet. Gynaecol. 1984; 24: 14-16.
5. 5 Lam SK, To WK, Duthie SJ, Ma HK. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust. N.Z. J. Obstet. Gynaecol. 1992; 32: 216-21.
6. 6 Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J. Pediatr. 1991; 118: 933-7.
7. 7 Theis JG, Selby P, Ikizler Y, Koren G. Current management of the neonatal abstinence syndrome: A critical analysis of the evidence. Biol. Neonate 1997; 71: 345-56.
8. 8 Finnegan LP, Kron, RE, Connaughton JF. A scoring system for evaluation and treatment of the neonatal abstinence syndrome, a clinical research tool. In: Morselli PL, Garratini S, Serini F, eds. Basic and Therapeutic Aspects of Perinatal Pharmacology. Raven Press, New York, 1975.
9. 9 Darte D. Self-report among injecting drug users: A review. Drug Alcohol Depend. 1998; 51: 265-6.
10. 10 Vance JC, Chant DC, Tudehope DI, Gray PH, Hayes AJ. Infants born to narcotic dependent mothers: Physical growth patterns in the first 12 months of life. J. Paediatr. Child Health 1997; 33: 504-8.
11. 11 Levy M, Spino M. Neonatal withdrawal syndrome: associated drugs and pharmacological management. Pharmacotherapy 1993; 13: 202-11.
12. 12 Crofts N, Ailken CK, Kaldor JM. The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med. J. Aust. 1999; 170: 220-1.
13. 13 Garland SM, Tabrizi S, Robinson P et al. Hepatitis C - role of perinatal transmission. Aust. N.Z. J. Obstet. Gynaecol. 1998; 38: 424-7.
14. 14 Kandall SR. Treatment strategies for the drug-exposed neonates (review of 68 refs). Clinics Perinatol. 1999; 26: 231-43.